Lotechek-LS Eye Drop contains Loteprednol etabonate 0.2% w/v, a corticosteroid indicated for the treatment of inflammatory conditions of the eye. It is primarily used to manage ocular inflammation and pain associated with allergic conjunctivitis, postoperative inflammation following ocular surgery, and other corticosteroid-responsive inflammatory conditions of the anterior segment of the eye. Loteprednol etabonate, a soft steroid, exerts its anti-inflammatory effects by inhibiting the release of inflammatory mediators, thereby reducing redness, swelling, and discomfort. The formulation is designed for topical ophthalmic use, ensuring targeted delivery with minimal systemic absorption. Lotechek-LS is generally well tolerated; however, prolonged use may increase the risk of elevated intraocular pressure, cataract formation, or secondary ocular infections. It is contraindicated in viral, fungal, or mycobacterial infections of the eye. Patients should be advised to avoid contact lenses during treatment unless otherwise directed by a healthcare professional. Proper administration involves instilling the prescribed number of drops into the affected eye(s) as directed, with adherence to hygiene to prevent contamination. Regular monitoring by an ophthalmologist is recommended to assess therapeutic response and detect potential adverse effects. Lotechek-LS Eye Drop offers an effective option for controlling ocular inflammation with a favorable safety profile when used appropriately.